Sign in
IBER Stock Price, Chart, Stats & News
Ibere Pharmaceuticals
Save
175.60M
Market cap
17.25x
Current P/E
–
Forward P/E
IBER chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | 1.13% |
ROE | 2.46% |
D/E | – |
Interest coverage ratio | – |
IBER valuation
P/E | 17.25x |
P/S | – |
P/B | 0.92x |
P/CF | -134.69x |
P/FCF | -202.14x |
P/OCF | -134.69x |
PEG | 0.75x |
EV multiple | -49.55x |
About
Ibere Pharmaceuticals currently lacks significant operational activities, with its core mission focused on executing a business combination. This could involve a merger, an acquisition of assets or shares, or a corporate restructuring with one or more other entities. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.
Similar securities
Based on sector and market capitalization
Report issue